Bionano Genomics, Inc. (BMV:BNGO)

Mexico flag Mexico · Delayed Price · Currency is MXN
31.00
-2.21 (-6.65%)
At close: Dec 3, 2025
-89.67%
Market Cap 311.04M
Revenue (ttm) 526.79M
Net Income (ttm) -707.77M
Shares Out n/a
EPS (ttm) -215.57
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 200
Average Volume 1,242
Open 31.00
Previous Close 33.21
Day's Range 31.00 - 31.00
52-Week Range 28.56 - 420.00
Beta n/a
RSI 36.34
Earnings Date Nov 13, 2025

About Bionano Genomics

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome anal... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2003
Employees 100
Stock Exchange Mexican Stock Exchange
Ticker Symbol BNGO
Full Company Profile

Financial Performance

In 2024, Bionano Genomics's revenue was $30.78 million, a decrease of -14.79% compared to the previous year's $36.12 million. Losses were -$112.02 million, -51.82% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.